Prev Arrow Stocks

Teladoc Health Inc. ($TDOC) Stock Forecast: Down 5.7% Today

Morpher AI identified a bearish signal. The stock price may continue to fall based on the momentum of the negative news.

What is Teladoc Health Inc.?

Teladoc Health, Inc. (NYSE: TDOC) is a leading telemedicine company that provides virtual healthcare services to patients worldwide. The company's stock experienced a significant bearish movement today amidst legal issues and investor alerts.

Why is Teladoc Health Inc. going down?

TDOC stock is down 5.7% on Jul 2, 2024 13:46

  • Teladoc Health, Inc. faced a bearish market movement following news of securities law violations and class action lawsuits, leading to investor concerns and selling pressure.
  • The legal issues surrounding TDOC, including securities law violations and class action lawsuits, likely contributed to the negative sentiment and downward pressure on the stock.
  • Despite the AI sector gaining momentum with notable investments in companies like Palantir Technologies Inc., TDOC's legal challenges overshadowed any potential positive market trends, causing a sharp decline in its stock price.
  • Investors are advised to closely monitor developments regarding the legal proceedings against Teladoc Health, Inc. and assess the potential impact on the company's financial performance and stock value.

TDOC Price Chart

TDOC News

Cathie Wood-Led Ark Invest Scoops Up $5.16M Worth Of Palantir Shares Amid Raging AI Fervor - Adaptive Biotechnologies ( NASDAQ:ADPT ) , ARK Autonomous Technology & Robotics ETF ( BATS:ARKQ )

On Monday, Cathie Wood-led Ark Invest made a notable investment in Palantir Technologies Inc PLTR, a move that comes as the AI sector gains momentum. Ark Invest, through its ARK Autonomous Technology & Robotics ETF ARKQ, purchased 199,372 shares of Palantir, a significant addition to its ...

https://www.benzinga.com/markets/equities/24/07/39587894/cathie-wood-led-ark-invest-scoops-up-5-16m-worth-of-palantir-shares-amid-raging-ai-fervor

News Article Image Cathie Wood-Led Ark Invest Scoops Up $5.16M Worth Of Palantir Shares Amid Raging AI Fervor - Adaptive Biotechnologies  ( NASDAQ:ADPT ) , ARK Autonomous Technology & Robotics ETF  ( BATS:ARKQ )

Teladoc Health, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before July 16, 2024 to Discuss Your Rights - TDOC - Teladoc Health ( NYSE:TDOC )

NEW YORK, July 01, 2024 ( GLOBE NEWSWIRE ) -- The Gross Law Firm issues the following notice to shareholders of Teladoc Health, Inc. TDOC. Shareholders who purchased shares of TDOC during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

https://www.benzinga.com/pressreleases/24/07/g39579462/teladoc-health-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-

News Article Image Teladoc Health, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before July 16, 2024 to Discuss Your Rights - TDOC - Teladoc Health  ( NYSE:TDOC )

7 F-Rated Blue-Chip Stocks That’ll Have You Seeing Red

I’ve long been a proponent of blue-chip stocks as reliable anchors in an investment portfolio. But you can’t buy them blindly. While there are outstanding blue-chip stocks out there, there’s the other side of the coin – F-rated blue-chip stocks that will do serious damage unless you properly identify them as stocks to sell. Blue-chip stocks represent names you already know – some of the most well-established and financially sound companies on the market. Blue chips are recognized leaders in their fields, sport large market capitalizations and usually offer enticing dividend payments. Using the Portfolio Grader, you can quickly identify which blue-chip names are underperforming the market. And you can even find some names doing so badly with earnings, revenue growth, momentum and analyst sentiment that they get a dreaded “F” rating. If you own an F-rated blue-chip stock, you are leaving money on the table that could be better utilized in more promising opportunities. Holding on comes with a lot of risk because a turnaround is not guaranteed, and if it comes at all, it could take a long time. Your money is better spent with highly rated stocks that will help you along your investing journey. These are some F-rated stocks to sell now. It’s not too late to divest from these underperforming blue chips and move your money to more promising opportunities.

https://investorplace.com/market360/2024/07/7-f-rated-blue-chip-stocks-thatll-have-you-seeing-red/

News Article Image 7 F-Rated Blue-Chip Stocks That’ll Have You Seeing Red

TDOC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Teladoc Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Teladoc Health ( NYSE:TDOC )

NEW YORK, July 01, 2024 ( GLOBE NEWSWIRE ) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Teladoc Health, Inc. ( "Teladoc" or "the Company" ) TDOC and certain of its officers.

https://www.benzinga.com/pressreleases/24/07/g39568758/tdoc-investor-alert-bronstein-gewirtz-grossman-llc-announces-that-teladoc-health-inc-investors-wit

News Article Image TDOC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Teladoc Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Teladoc Health  ( NYSE:TDOC )

ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Teladoc Health

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Teladoc To Contact Him Directly To Discuss Their Options

https://www.globenewswire.com/news-release/2024/06/28/2905917/683/en/ONGOING-DEADLINE-ALERT-Faruqi-Faruqi-LLP-Investigates-Claims-on-Behalf-of-Investors-of-Teladoc-Health.html

News Article Image ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Teladoc Health

Teladoc Health Inc. Price History

01.06.2024 - TDOC Stock was down 5.1%

  • Today's bearish movement in TDOC can be attributed to the following factors:
  • The company is facing multiple class-action lawsuits for securities law violations, leading to uncertainty and negative sentiment among investors.
  • The legal challenges and investor alerts regarding substantial losses may have further fueled concerns about the company's financial stability.
  • The negative publicity and ongoing investigations could be eroding investor confidence in TDOC's long-term growth prospects, prompting a sell-off of the stock.
  • The overall market sentiment towards TDOC may have been influenced by the broader trend of investors divesting from underperforming blue-chip stocks.

01.06.2024 - TDOC Stock was down 5.0%

  • Teladoc's stock witnessed a downturn in recent trading.
  • Recent sell-offs by a prominent investment firm, as well as general market pessimism towards low-rated blue-chip stocks, likely contributed to the decline in Teladoc's stock value.
  • The broader market volatility, particularly within the telemedicine sector, played a significant role in influencing investors' negative outlook on Teladoc's performance.

25.05.2024 - TDOC Stock was down 5.9%

  • Teladoc stock faced a decline possibly due to a class action lawsuit from investors with significant financial losses.
  • While news of increased engagement from diabetic users through an AI-modeling system briefly boosted the stock, it was overshadowed by the negative impact of the lawsuit.
  • Industry sentiment towards telemedicine firms like Teladoc may have been affected by market uncertainties, including regulatory concerns and legal issues.
  • The market also felt the effects of Cathie Wood's Ark Invest selling off Coinbase shares amid declining Bitcoin values, contributing to a generally pessimistic mood that influenced Teladoc's stock and others in the sector.

25.05.2024 - TDOC Stock was down 5.3%

  • Teladoc stock declined due to a class action lawsuit filed by investors, impacting investor confidence negatively.
  • The positive news about increased engagement among diabetes members through predictive AI-modeling was outweighed by the overshadowing legal concerns.
  • ARK Invest, led by Cathie Wood, selling Teladoc shares added to the downward pressure on the stock.
  • Legal challenges, decreased investor interest, and the significant divestment by Cathie Wood likely contributed to the bearish trend of Teladoc Health Inc today.

24.05.2024 - TDOC Stock was up 5.5%

  • Teladoc Health's announcement of increased engagement among diabetes members through its predictive AI-modeling likely boosted investor confidence, leading to a bullish movement in the stock.
  • The class action lawsuit news might have caused some uncertainty among investors initially, but the positive engagement results overshadowed these concerns, contributing to the stock's upward momentum.
  • Cathie Wood's ARK Invest selling Teladoc stock may have initially caught attention, but the company's initiative to offer free virtual health care services to New Mexico residents impacted by wildfires could have earned positive attention and goodwill from investors, further fueling the bullish movement in the stock.

24.05.2024 - TDOC Stock was up 5.5%

  • Despite the ongoing class action lawsuit, the stock experienced a bullish movement, possibly indicating investor confidence in the company's ability to navigate legal challenges.
  • Cathie Wood's ARK Invest shifting its focus by selling stock could have initially caused a slight dip in TDOC's price, but the subsequent bullish movement suggests that other investors may see value in the company's offerings.
  • The news of Teladoc Health providing free virtual health care services to New Mexico residents affected by wildfires could have positively impacted the stock, showcasing the company's commitment to social responsibility and potentially attracting more users to its platform.
  • Overall, the combination of legal developments, investor sentiment, and positive community engagement initiatives likely contributed to the bullish movement in the stock today.

13.05.2024 - TDOC Stock was down 6.4%

  • Teladoc stock displayed a bearish trend today despite the recent appointment of Charles Divita as the new CEO.
  • A neutral rating from BofA during the CEO transition might have contributed to investor uncertainty regarding the company's future direction.
  • Some market participants view Teladoc as a risky investment, with mentions of it being referred to as "Once a Pioneer, Now a Gamble."
  • While there is a positive outlook on small-cap stocks making a comeback and potentially providing significant returns, Teladoc faces specific challenges that could have caused the bearish movement in its stock price.

14.04.2024 - TDOC Stock was up 6.6%

  • Teladoc (TDOC) experienced a bullish movement today.
  • The healthcare sector, including telemedicine companies like Teladoc, has been undervalued recently due to shifting investor focus towards other sectors like technology.
  • Recent selling of Teladoc stock by a prominent investor might have initially impacted the price negatively, but the undervalued nature of healthcare stocks could have attracted new investors, leading to the bullish movement.
  • As the global disease burden continues to rise, the demand for telemedicine services provided by companies like Teladoc could see a resurgence, contributing to the positive market movement.

08.04.2024 - TDOC Stock was down 5.1%

  • Teladoc Health's stock faced downward pressure despite offering free virtual health care services to Oklahoma residents affected by tornadoes.
  • Concerns related to Cathie Wood's underperforming stocks and the withdrawal of funds from her ETFs likely influenced the negative movement in TDOC's stock.
  • Market apprehensions about the company's financial performance and investor sentiment may be overshadowing the positive outcomes of its charitable initiatives.
  • Investor hesitance regarding the company's growth potential in a shifting market environment could be driving the sell-off, despite its positive community involvement efforts.

05.03.2024 - TDOC Stock was down 5.4%

  • The sudden departure of CEO Jason Gorevic after the stock's significant 95% fall from 2021 highs.
  • CFO Mala Murthy appointed as acting chief executive during the transition period.
  • The leadership transition announcement by the Teladoc Health Board of Directors led to uncertainty and a lack of confidence in the company's future direction.
  • Investors reacted negatively to the news, causing a bearish movement in TDOC stock as they assess the impact of the CEO's departure on the company's strategic direction and performance.

23.01.2024 - TDOC Stock was down 5.0%

  • Teladoc stock plummeted due to weak guidance, leading to a gap down to a support level.
  • The lack of positive news or developments for the company contributed to the downward trend.
  • Investors may be concerned about the company's future prospects and its ability to maintain its client base, despite having prominent clients like half of the Fortune 500 companies.
  • The overall sentiment towards telehealth stocks might have also played a role in the bearish movement of Teladoc, as investors reassess the sector's growth potential.

23.01.2024 - TDOC Stock was down 5.1%

  • Teladoc Health (TDOC) stock showed a bearish movement recently.
  • This decline may be due to the company providing weak guidance, causing the stock to drop to a support level.
  • Despite its popularity among investors, concerns about the company's future performance may have led some traders to sell their shares.
  • While other companies like BuzzFeed (BZFD) and Agile Therapeutics (AGRX) saw significant stock price increases, this positive news did not impact Teladoc Health's bearish trend.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.